Market Overview

UPDATE: Sterne Agee Initiates Cerner at Neutral on Valuation

Share:
Related CERN
Cerner to Replace Department of Defense's Anatomic Pathology Laboratory Information System
Healthcare IT Investors: Oppenheimer Just Made Some Waves
Will Cerner's (CERN) Earnings Pull a Surprise in Q2? - Analyst Blog (Zacks)

In a report published Wednesday, Sterne Agee analyst Greg T. Bolan initiated coverage on Cerner (NASDAQ: CERN) with a Neutral rating and $100.00 price target.

In the report, Sterne Agee noted, “At this point, we believe Cerner's bookings will grow at to slightly better than mid-teens growth in CY12. While impressive, we believe the current valuation of Cerner's stock reflects our optimistic outlook. Initiate coverage with a Neutral rating and $100 price target.”

Cerner closed on Tuesday at $98.14.

Latest Ratings for CERN

DateFirmActionFromTo
Jun 2015OppenheimerInitiates Coverage onOutperform
Apr 2015SunTrust Robinson HumphreyDowngradesBuyNeutral
Apr 2015BarclaysMaintainsBuy

View More Analyst Ratings for CERN
View the Latest Analyst Ratings

Posted-In: Greg T. Bolan Sterne AgeeAnalyst Color Initiation Analyst Ratings

 

Related Articles (CERN)

Get Benzinga's Newsletters